Whether, in light of the fact that research shows that the Molnupiravir and/or Paxlovid pills lower the likelihood of hospitalisation and death in patients at high risk of falling seriously ill if they are taken within the first five days of COVID-19 symptoms, and since the vaccine injections do not actually eradicate the virus, but also assist in eliminating the risk of death and the likelihood of hospitilisation, of which the pill can do the same probably at a lower cost, his department will consider the availability of COVID-19 pills once authorised by SA Health Products Regulatory Authority; if not, what is the position in this regard; if so, what are the relevant details?